Login

Journal Front Page

News & Events

  • April 2024 Issue delayed
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, Volume 13, Issue 2 (April 2024) Issue) schedule published on 15 April 2024 is delay due to some technical problem. It will published on 22 April 2024. Sorry for inconvenience. For other details You can vist the website http://www.ajper.com
  • Call for article for April 2024 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 March, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • January 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 1 (January 2024) Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

STABILITY-INDICATING RP-HPLC METHOD FOR ANALYSIS OF EMTRICITABINE IN THE BULK DRUG AND IN A PHARMACEUTICAL DOSAGE FORM

Aditya Kumar Suman*, B.K.Dubey, Bhushan Korde, Brijesh Mishra

Technocrats institute of technology (pharmacy) Bhopal

ABSTRACT

A novel stability-indicating RP-HPLC method has been developed and validated for quantitative analysis of Emtricitabine (EMT) in the bulk drug and in a pharmaceutical dosage form. An isocratic separation of EMT was achieved on Thermo C18 column (4.6 x 250mm, 5 μ particle size) as the stationary phase with a flow rate of 1 ml/min and using a UV detector to monitor the eluate at 254nm. The mobile phase consisted of 10mM KH2PO4: methanol (20:80v/v) and pH adjusted 3.0 by orthophosphoric acid enabled separation of the drug from its degradation products. The method was validated for linearity, accuracy (recovery), precision, specificity, and robustness. The linearity of the method was satisfactory over the range5-25μg/ml (correlation coefficient 0.9998). The limits of detection and quantification were 0.23 and 0.96μg/ml respectively. Recovery of EMT from the pharmaceutical dosage form ranged from 98.00 to 99.00%. EMT was subjected to stress conditions (hydrolysis (acid, base), oxidation, photolysis, and thermal degradation) and the samples were analyzed by this method. Extensive degradation was found under acid, photolytic and oxidative stress. The degradation products were well resolved from main peak. The forced degradation study proved the stability indicating power of the method and therefore, the validated method may be useful for routine analysis of EMT as bulk drug, in respective dosage forms, for dissolution studies and as stability indicating assay method in pharmaceutical laboratories and industries.

Keywords: RP-HPLC, Emtricitabine, Forced degradation, Method validated


[Full Text Article]